Search clinical trials for: CMV viral load

Total 25798 results

Universidad San Francisco de Quito

Unknown

Isoprinosine in HIV Patients With Viral Load > 50 y < 200 Copies/mL

HIV Infections

Ecuador
National Institute of Allergy and Infectious Diseases...

Completed

VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...

HIV-1 Infection | HIV Antibodies | Neutralizing Antibody | Viral Load | Monoclonal Antibody

United States
National Heart, Lung, and Blood Institute (NHLBI)

Terminated

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | MDS (Myelodysplastic Syndrome) | CML (Chronic Myelogenous Leukemia) | AML (Acute Myelogenous Leukemia)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring

Acquired Immunodeficiency Syndrome | Resistance

Uganda
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain

HIV Infections

Spain
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

HIV Infections

Spain
Assistance Publique - Hôpitaux de Paris

Terminated

Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance (GANCIMVEAR)

Congenital Cytomegalovirus (CMV)

France
Shaare Zedek Medical Center

Unknown

The Maternal Cellular Immune System and Cytomegalovirus Intrauterine Infection

Pregnant Women | Cytomegalovirus Infections

Israel
University of Minnesota

Completed

Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients

CMV Viremia | EBV Viremia

United States
University Hospital, Limoges

Terminated

Assessing the Risk of CMV Infection of the Renal Transplant About R + by Cellular Immunity Analyzed by the QuantiFERON ®-CMV Test. (QUANTIC-R+)

Renal Transplant Recipient | Immunized Against the Cytomegalovirus

France
University Hospital, Limoges

Completed

A French Cohort of Transplant Recipients With CMV Infection : Risk Factors for Antiviral Resistance in the Prophylaxis Era. (ORPHAVIC)

Transplant Recipients With CMV Infection

France
World Bank
Department for International Development, United Kingdom; Wits Reproductive... and other collaborators

Completed

Smart Linkage-to-HIV Care Via a Smartphone App (SmartLtC)

HIV Infections | Antiretroviral Therapy | Patient Compliance | Viral Load | Cell Phone

South Africa
Beijing Ditan Hospital

Unknown

Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B

Chronic Hepatitis B Infection | High Viral Load

China
National Institute of Allergy and Infectious Diseases...

Completed

HIV Expression in Patients With Low Viral Load on Highly Active Antiretroviral Therapy (HAART)

HIV Infections

United States
University of Giessen
Novartis; Astellas Pharma US, Inc.; German Cancer Research Center; Heidelberg University

Completed

Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

Kidney Transplantation | Immunology | Virus | Living Donors | Rituximab (RTx)

Germany
Shenzhen Geno-Immune Medical Institute

Unknown

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Tuberculosis | CMV Infection | EBV Infection | Adenovirus Infection | Fungus Infection | Pathogen Infection | BKV Infection

China
Merck Sharp & Dohme LLC

Completed

Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)

Prevention of CMV Infection or Disease
Johns Hopkins University
National Institute on Drug Abuse (NIDA); National Institute of Mental Health... and other collaborators

Completed

Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations

HIV Infection

India
Rabin Medical Center

Completed

Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy

Congenital Cytomegalovirus Infection

Israel
Macfarlane Burnet Institute for Medical Research...
Gilead Sciences

Completed

Rapid Point-of-care Testing for Hepatitis C in Community Clinics (RAPID-EC) Pilot Study

Hepatitis C

Australia
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France; Fondation... and other collaborators

Unknown

Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia (Cam-C)

Hepatitis C | Testing
AlloVir
Baylor College of Medicine; The Methodist Hospital Research Institute; Center...

Completed

ARMS - Rapidly Generated Multivirus-Specific CTLs for Prophylaxis & Treatment of EBV, CMV, Adenovirus, HHV6 & BK Virus (ARMS)

Viral Infection

United States
Astellas Pharma Global Development, Inc.
Vical

Completed

An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients

Healthy Subjects | Cytomegalovirus Infection | Dialysis

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

Primary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid... and other conditions

United States
Jun Zhang
National Natural Science Foundation of China; Merck Sharp & Dohme LLC

Completed

A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China

Congenital Cytomegalovirus Infection | Cytomegalovirus Infection Reactivation

China
Atara Biotherapeutics

No longer available

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

CMV Viremia | CMV Disease
Seoul National University Hospital

Completed

The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular | Chronic Hepatitis B

Korea, Republic of
University of Sao Paulo General Hospital

Unknown

Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV

Kidney Transplant Infection | CMV | Cytomegalovirus Infections

Brazil
Ronaldo de Matos Esmeraldo, MD
Novartis Pharmaceuticals

Completed

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Cytomegalovirus Infections | Transplantation Infection

Brazil
Foundation for Liver Research

Completed

Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (PEGON)

Chronic Hepatitis B

Netherlands, China
Min Wang
First Hospital of China Medical University; The First People's Hospital of... and other collaborators

Unknown

HR-HPV Multi-site Opportunistic Screening in Liaoning, China

Cervical Cancer

China
AlloVir

Completed

Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)

CMV Infections

United States
University Hospital, Bordeaux
Novartis

Completed

Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A (EVERCMV)

Transplantation Infection | Cytomegalovirus Infection

France
University of Pennsylvania
National Institute on Drug Abuse (NIDA)

Completed

Adherence to HIV Therapy in Heroin Addicts: Oral vs XR-NTX

HIV Infections | HIV | Substance Abuse

Russian Federation
National Institute of Allergy and Infectious Diseases...

Completed

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

HIV, Inflammation

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); Johns Hopkins University; Thai Nguyen...

Completed

Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load (REDART)

Alcohol Drinking | HIV

Vietnam
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults

HIV Infections

Peru, Brazil, South Africa, Uganda, Botswana, Haiti, Zambia, Zimbabwe
Medical University of South Carolina
CSL Behring

Completed

Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection

Cytomegalovirus Disease

United States
ORIOL BESTARD

Completed

Prospective, Randomized Study for Predicting Human Cytomegalovirus (hCMV) Infection Based on Baseline hCMV Specific T-cell Response in Kidney Transplant (RESPECT)

Kidney Transplantation | CMV Infection

Spain, Belgium
University of Miami

Completed

Trauma Intervention for Affect Regulation, AIDS, and Substances (TIARAS)

Post Traumatic Stress Disorder | Human Immunodeficiency Virus | Substance Related Disorder

United States
University College, London

Suspended

Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT (CMV_TCR-001)

CMV Infection | Haematological Malignancies

United Kingdom
Asan Medical Center
Hanyang University; Kangbuk Samsung Hospital; Eulji University Hospital

Unknown

Reversible Cerebral Vasoconstriction Syndrome and Varicella Zoster Virus (RCVS&VZV)

Reversible Cerebral Vasoconstriction Syndrome | Varicella-zoster Virus Infection

Korea, Republic of
Public Health England
Royal Free and University College Medical School

Completed

Response of Older Adults to Influenza Vaccination With Regard to Cytomegalovirus (CMV) Status (CMVflu)

Influenza

United Kingdom
Lophius Biosciences GmbH
German Federal Ministry of Education and Research

Completed

Clinical Validation of Lophius Biosciences Kit T-Track® CMV in Allo-HSCT Recipients (AlloProtectCMV)

Cytomegalovirus Infection | GVHD

Germany
Beth Israel Deaconess Medical Center
Roche Molecular Systems, Inc; Bach Mai Hospital

Completed

The VMVN Study: Virological Monitoring in Viet Nam (VMVN)

HIV Infection | AIDS

Vietnam
Aier School of Ophthalmology, Central South University

Completed

High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

Uveitis, Posterior | Infection Viral
Cantonal Hospital of St. Gallen
Swiss National Science Foundation; Swiss HIV Cohort Study

Terminated

HIV - Monotherapy in Switzerland (MOST-ch) (MOST)

HIV Infections

Switzerland
SL VAXiGEN
SL BIGEN

Unknown

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

BK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus Reactivation

Korea, Republic of
Willem Daniel Francois Venter
Medical Research Council, South Africa

Completed

Evaluation of Low-dose Darunavir in a Switch Study (DRV)

HIV Infections

South Africa
Southern Illinois University
University of Alabama at Birmingham

Completed

Screening for Congenital Cytomegalovirus Infection in Newborns (CMV)

Cytomegalovirus Infections

Search clinical trials for: CMV viral load

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations